1Gotto AM.Low high-density lipoprotein cholesterol as a risk factor in coronary heart disease:a working group report,2001(17). 被引量：1
2Anderson TJ.Assessment and treatment of endothelial dysfunction in humans[J],1999(03). 被引量：2
3Watts GF;O′Brien SF;Silvester W.Impaired endothelium dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes:role of dyslipidaemia,1996(05). 被引量：1
4Murohara T;Kugiyama K;Ohgushi M.LPC in oxidized LDL elicits vasocontraction and inhibits endothelium-dependent relaxation,1994. 被引量：1
5Blair A;Shaul PW;Yuhanna IS.Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase(eNOS)from plasmalemmal caveolae and impairs eNOS activation[J],1999(45). 被引量：1
6Uittenbogaard A;Shaul PW;Yuhanna IS.High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae[J],2000(15). 被引量：1
7Cominacini L;Rigoni A;Pasini AF.The binding of oxidized low density lipoprotein(ox-LDL)to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide,2001. 被引量：1
8O′Connell BJ;Genest J.High-density lipoproteins and endothelial function[J],2001(16). 被引量：1
9Naqvi TZ;Shah PK;Ivey PA.Evidence that high-density lipoprotein cholesterol is an independent predictor of acute platelet-dependent thrombus formation,1999(09). 被引量：1
10Cigolini M;Targher G;Seidell JC.Relationships of plasminogen activator inhibitor-1 to anthropometry serum insulin triglycerides and adipose tissue fatty acide in healthy men,1994(02). 被引量：1
3Libby P, Aikawa M, Schonbeck U. Cholesterol and atherosclerosis[ J ]. Biachim Biophy Acta, 2000, 1529 ( 1-3 ) : 299. 被引量：1
4Gotto A M, Whitney E, Stein E A, et al. Relationship between baseline and on - treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronarya Atherosclerosis Prevention Study ( AFCAPS/Tex CAPS) [ J ] . Circulation, 2000, 101 (5) : 477. 被引量：1
5Brewer HB Jr. Increasing HDL Cholesterol Levels[J] . N Eng J Med,2004,350(15) :1 491. 被引量：1
6Li X, Chyu KY, Faria Neto JR, et al. Differential Effects of Apolipoprotein A - I - mimetic peptide on evolving and established atherosclerosis in apolipoprotein E- null mice[J]. Circulation ,2004,110(12) : 1 701. 被引量：1
7Michae IM. Niacin as acomponent of combination therapy for dyslipidemia [ J ]. Mayo Clin Proc, 2003,78 (6) : 735. 被引量：1
8Ganji SH Kamanna VS, Kashyap ML. Niacin and cholesterol: role in cardiovascular disease (review)[ J]. J Nutr Biolchem, 2003,14(6) :298. 被引量：1
9Kajinami K,Takekeshi N. Cholesterol absorption inhibitors in development as potential therapeutics[ J]. Expert Opin lnvestig Drugs ,2002,11 (6) :831. 被引量：1
10Rosenson RS, Otvos JD, Freedman DS. Relations of lipoprotein subclass levels and low - density lipoprotein size to progression of coronary artery disease in the Pravastain Limitation of Atherosclerosis in the Coronary Arteries(PLAC - Ⅰ) trial[J]. AM J Cardiol,2002,90( 2 ) :89. 被引量：1
